Celebrex Seen Raising Risk of Heart Disease ; Pfizer Decides Not to Recall Its Arthritis Drug
The Washington Times › December 19, 2004
Linked as:
Summary
Celebrex, the nation's best-selling painkiller, raises the risk of heart disease, the federal government said yesterday, the same problem that led to the withdrawal of its competitor Vioxx.
Its manufacturer, New York pharmaceutical giant Pfizer Inc., said it would not recall the arthritis drug, a spokeswoman said yesterday. She would not comment further.See the full content of this document
Extract
Celebrex Seen Raising Risk of Heart Disease ; Pfizer Decides Not to Recall Its Arthritis Drug
As of Sept. 30, more than 27 million U.S. patients had been prescribed Celebrex, though that number jumped significantly after Vioxx was pulled from pharmacy shelves, the company said.
The announcement c...See the full content of this document
Sponsored links
